Author:
Jankowski Marek,Wandtke Tomasz
Publisher
Springer International Publishing
Reference201 articles.
1. Airoldi I, Tupone MG, Esposito S, Russo MV, Barbarito G, Cipollone G, Di Carlo E (2015) Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer. Oncotarget 6(6):3694–3708. doi: 10.18632/oncotarget.2797
2. Amadi-Obi A, Yu CR, Dambuza I, Kim SH, Marrero B, Egwuagu CE (2012) Interleukin 27 induces the expression of complement factor H (CFH) in the retina. PLoS ONE 7(9):e45801. doi: 10.1371/journal.pone.0045801
3. Anderson CF, Stumhofer JS, Hunter CA, Sacks D (2009) IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J Immunol 183(7):4619–4627. doi: 10.4049/jimmunol.0804024
4. Angata T, Ishii T, Gao C, Ohtsubo K, Kitazume S, Gemma A, Kida K, Taniguchi N (2014) Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary disease. Phys Rep 2(7). doi:10.14814/phy2.12069
5. Babaloo Z, Yeganeh RK, Farhoodi M, Baradaran B, Bonyadi M, Aghebati L (2013) Increased IL-17A but decreased IL-27 serum levels in patients with multiple sclerosis. Iranian journal of immunology: IJI 10 (1):47-54. doi:IJIv10i1A6